GRAIL secures FDA breakthrough device designation for multi-cancer test
GRAIL, a healthcare company with a mission to detect cancer early, has secured the Breakthrough Device designation from…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 May 19
GRAIL, a healthcare company with a mission to detect cancer early, has secured the Breakthrough Device designation from…
10 May 19
This week Philips submitted an application to the FDA for approval of its latest innovation in lead management…
08 May 19
LunaPBC, founder of LunaDNA, the first community-owned genomic and health data platform, has closed $4.6m in new funding,…
07 May 19
PrediLife has partnered with the Institut Curie to launch the next-generation of its MammoRisk, a test predicting breast…
07 May 19
Natera, a US-based genetic testing company and CLIA-certified laboratory operator, has received the Breakthrough Device designation from the…
06 May 19
Caris Life Sciences has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its…
03 May 19
Healthcare firm Abbott has secured World Health Organization's Prequalification approval (WHO PQ) for its m-PIMA HIV-1/2 VL point-of-care…
01 May 19
Meridian Bioscience has agreed to acquire Debiopharm Group’s subsidiary GenePOC in a deal valued at around $120m.
25 Apr 19
Henry Schein Medical, the US medical business of Henry Schein announced today its new private label-branded product, OneStep…
25 Apr 19
Boston-based biomedical software company BostonGene has secured a $50m Series A strategic investment from Tokyo-based IT services and…